Effects of Statin Treatment on Patients with Angina and Normal or Nearly Normal Angiograms

Olivia Manfrini1, Peter Amaduzzi1, Maria Bergami1

  • 1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna Bologna, Italy.

Insights

This study reviews statin treatment effects in patients experiencing chronic angina without obstructive coronary artery disease. Findings highlight statins

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Chronic angina often presents without obstructive epicardial coronary artery disease, posing diagnostic and therapeutic challenges.
  • The role of statin therapy in this specific patient population remains an area of active investigation.

Purpose of the Study:

  • To provide a comprehensive overview of current evidence regarding the efficacy and safety of statin treatment in patients with chronic angina and non-obstructive coronary artery disease.
  • To synthesize major findings from recent research to inform clinical practice.

Main Methods:

  • Systematic literature review of randomized controlled trials and observational studies.
  • Analysis of data focusing on symptom improvement, quality of life, and cardiovascular event rates.
  • Synthesis of findings related to different statin classes and dosages.

Main Results:

  • Evidence suggests potential benefits of statin therapy in select patients with chronic angina and non-obstructive coronary artery disease, particularly those with elevated cardiovascular risk.
  • Statin treatment may improve angina symptoms and reduce the need for revascularization procedures in some individuals.
  • Further research is needed to precisely identify patient subgroups who benefit most from statin therapy.

Conclusions:

  • Statin therapy may be considered in patients with chronic angina and non-obstructive coronary artery disease, especially in the presence of other cardiovascular risk factors.
  • Personalized treatment approaches are crucial, considering individual patient characteristics and risk profiles.
  • Continued research is essential to refine treatment guidelines for this complex patient group.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
186
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
230
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
148
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
206
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
174